Amneal Pharmaceuticals, Inc. AMRX Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s stock issuance proceeds?
- Amneal Pharmaceuticals, Inc. (AMRX) reported stock issuance proceeds of $38K in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s stock issuance proceeds changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s stock issuance proceeds decreased by 44.9% year-over-year, from $69K to $38K.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s stock issuance proceeds?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s stock issuance proceeds has grown at a 23.1% compound annual growth rate (CAGR), from $853K to $1.96M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.